Search research articles
Contact Us
Filters
Showing results (41-50 of 119) with videos related to
Page
of 12
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 4, 2003
17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study
Laura D Baker, Kumar Sambamurti, Suzanne Craft, et al.
Breast Cancer Research and Treatment
|
June 11, 2013
T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity
Denise L Cecil, Kyong Hwa Park, Ekram Gad, et al.
The Prostate
|
May 15, 2003
Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts
Marie K Tennant, Robert L Vessella, Cynthia C Sprenger, et al.
Neoplasia (New York, N.Y.)
|
December 3, 2008
Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells
Cynthia C T Sprenger, Rolf H Drivdahl, Lillie B Woodke, et al.
Nature Reviews. Clinical Oncology
|
August 24, 2018
Alternative splicing in prostate cancer
Alec Paschalis, Adam Sharp, Jonathan C Welti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors
Jennifer D Wu, Kathy Haugk, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2007
An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer
Stephen R Plymate, Kathy Haugk, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2011
Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants
Elahe A Mostaghel, Brett T Marck, Stephen R Plymate, et al.
Oncotarget
|
May 16, 2013
Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
Joanna L Gillis, Luke A Selth, Margaret M Centenera, et al.
Plos One
|
November 25, 2011
Androgen receptor variants occur frequently in castration resistant prostate cancer metastases
Xiaotun Zhang, Colm Morrissey, Shihua Sun, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 119) with videos related to
Sort By:
Page
of 12
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 4, 2003
17beta-estradiol reduces plasma Abeta40 for HRT-naïve postmenopausal women with Alzheimer disease: a preliminary study
Laura D Baker, Kumar Sambamurti, Suzanne Craft, et al.
Breast Cancer Research and Treatment
|
June 11, 2013
T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity
Denise L Cecil, Kyong Hwa Park, Ekram Gad, et al.
The Prostate
|
May 15, 2003
Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts
Marie K Tennant, Robert L Vessella, Cynthia C Sprenger, et al.
Neoplasia (New York, N.Y.)
|
December 3, 2008
Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells
Cynthia C T Sprenger, Rolf H Drivdahl, Lillie B Woodke, et al.
Nature Reviews. Clinical Oncology
|
August 24, 2018
Alternative splicing in prostate cancer
Alec Paschalis, Adam Sharp, Jonathan C Welti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2006
Combined in vivo effect of A12, a type 1 insulin-like growth factor receptor antibody, and docetaxel against prostate cancer tumors
Jennifer D Wu, Kathy Haugk, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 3, 2007
An antibody targeting the type I insulin-like growth factor receptor enhances the castration-induced response in androgen-dependent prostate cancer
Stephen R Plymate, Kathy Haugk, Ilsa Coleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2011
Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants
Elahe A Mostaghel, Brett T Marck, Stephen R Plymate, et al.
Oncotarget
|
May 16, 2013
Constitutively-active androgen receptor variants function independently of the HSP90 chaperone but do not confer resistance to HSP90 inhibitors
Joanna L Gillis, Luke A Selth, Margaret M Centenera, et al.
Plos One
|
November 25, 2011
Androgen receptor variants occur frequently in castration resistant prostate cancer metastases
Xiaotun Zhang, Colm Morrissey, Shihua Sun, et al.
Page
of 12